Cover Image
close this bookUNAIDS-Sponsored Regional Workshops to Discuss Ethical Issues in Preventive HIV Vaccine Trials (UNAIDS, 2000, 52 p.)
close this folderWORKSHOP REPORTS
close this folderBANGKOK, THAILAND, 20-22 APRIL, 1998
View the document1. Collaboration in Phase I, II and III Trials
View the document2. Community
View the document3. Ethical and Scientific Review
View the document4. Intellectual Property
View the document5. Control Arm in Trials
View the document6. Informed Consent
View the document7. Gender, Pregnancy and Breast-Feeding
View the document8. Children
View the document9. Protection from Discrimination
View the document10. Vaccine-Induced HIV-Seropositivity
View the document11. Counselling
View the document12. Post-Exposure Prophylaxis (PEP)
View the document13. Treatment and Care
View the document14. Compensation
View the document15. Availability of Vaccine
Expanding the text here will generate a large amount of data for your browser to display

10. Vaccine-Induced HIV-Seropositivity


The sponsor must provide the capacity for differential confirmatory testing for those who develop vaccine-induced seropositivity.